Literature DB >> 2725059

Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia.

W D Ludwig1, C R Bartram, J Harbott, U Köller, O A Haas, T Hansen-Hagge, G Heil, H Seibt-Jung, J V Teichmann, J Ritter.   

Abstract

We have studied the immunophenotypic and genotypic features in 35 infants aged less than 1 year with acute lymphoblastic leukemia (ALL) or acute undifferentiated leukemia (AUL). A CD10 (common ALL antigen)-negative, CD19-positive pre-pre-B ALL phenotype was observed in 24 infants. Seventeen of them had blast cells coexpressing myeloid-associated markers such as CD15A (VIM-D5, MZ17) and/or VIM-2, but neither myeloperoxidase nor platelet peroxidase was detected in five of these cases analyzed by electron microscopy. Five patients showed a typical common ALL, five a pre-B ALL phenotype, and one infant was unclassifiable by surface-marker and morphologic analysis. Cytogenetic data, available in 21 of these patients, revealed chromosomal abnormalities involving 11q23 in 10 infants with a CD10-negative pre-pre-B ALL. Immunoglobulin (Ig) and T cell receptor (TCR) gamma, beta and delta gene analysis of 31 infants showed Ig heavy-chain gene rearrangement in all but one patient with evidence for clonal evolution in six and kappa-light-chain rearrangement in three infants. TCR beta-chain and TCR gamma-chain rearrangement occurred in six and five patients respectively, while TCR delta-chain rearrangement was identified in 15 patients. Our data indicate that ALL in infancy may present with heterogeneous immunophenotypic and genotypic features. The high frequency of coexpression of B-lineage and myeloid surface markers as well as of chromosomal rearrangement involving 11q23 suggests that the clonogenic cell of infant ALL may relate to a multipotent progenitor cell in most cases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725059

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  5 in total

1.  Routine immunophenotyping of acute leukemias.

Authors:  W D Ludwig; E Thiel
Journal:  Blut       Date:  1990-01

2.  Leukemia in infants.

Authors:  Saika Somjee; Rupa Sapre; Shaila Shinde; Ashok Kumar; Subodh Dhond; Y Badrinath; Shashikant Mahadik; Anuradha Chougale; Rasheeda Ansari; C N Nair; S H Advani
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

3.  Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.

Authors:  J Vormoor; J Ritter; U Creutzig; J Boos; P Heyen; W D Ludwig; J Harbott; H Löffler; G Schellong
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  Cytogenetic findings in acute leukaemias of infants.

Authors:  F Lampert; J Harbott; J Ritterbach
Journal:  Br J Cancer Suppl       Date:  1992-08

5.  Prognostic significance of cell surface phenotype in acute lymphoblastic leukemia.

Authors:  Shiek Aejaz Aziz; Susheel Kumar Sharma; Iram Sabah; M Aleem Jan
Journal:  South Asian J Cancer       Date:  2015 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.